Status:
COMPLETED
Effects of Photobiomodulation on Changes in Cognitive Function and rCBF in MCI
Lead Sponsor:
Pusan National University Yangsan Hospital
Conditions:
Regional Cerebral Blood Flow
Mild Cognitive Impairment
Eligibility:
All Genders
55+ years
Phase:
NA
Brief Summary
This pilot study has two goals. The first is to see if the cognitive improves when VA and CA are stimulated in MCI patients, and the second is to do an explanatory data analysis to see if that improve...
Detailed Description
After being informed about the study and potential risks, all patients giving written informed codsent sill undergo a 1 day screening period to determine eligibility for study entry. Subjects who pass...
Eligibility Criteria
Inclusion
- The patients with mild cognitive impairment(MCI). The MCI was diagnosed based on medical history and neurological examination
- A sufficient level of education to understand study procedures and be able to communicate with site personnel
Exclusion
- Any psychiatric disorders such as schizophrenia that would compromise participation
- Those with central nervous system disease
- Serious cognitive problems(MoCA score 7 or less).
Key Trial Info
Start Date :
December 12 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2020
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT04721093
Start Date
December 12 2019
End Date
June 30 2020
Last Update
January 22 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pusan national university Yangsan Hospital
Gyeongsang, Yangsan, South Korea, 50610